Home/Pipeline/mRNA-4157

mRNA-4157

Personalized Cancer Vaccine

Phase 2Active

Key Facts

Indication
Personalized Cancer Vaccine
Phase
Phase 2
Status
Active
Company

About Moderna

Moderna, Inc. is a biotechnology company that harnesses the fundamental role of mRNA to translate genes into proteins to develop a new generation of transformative medicines for patients. The company created one of the most effective COVID-19 vaccines and has built a diverse development pipeline of mRNA medicines across multiple therapeutic areas. Moderna's platform approach enables rapid development of new treatments and vaccines by programming cells to produce therapeutic proteins.

View full company profile